Success Metrics

Clinical Success Rate
100.0%

Based on 6 completed trials

Completion Rate
100%(6/6)
Active Trials
2(22%)
Results Posted
0%(0 trials)

Phase Distribution

Ph phase_3
3
33%
Ph phase_4
1
11%
Ph phase_1
5
56%

Phase Distribution

5

Early Stage

0

Mid Stage

4

Late Stage

Phase Distribution9 total trials
Phase 1Safety & dosage
5(55.6%)
Phase 3Large-scale testing
3(33.3%)
Phase 4Post-market surveillance
1(11.1%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

85.7%

6 of 7 finished

Non-Completion Rate

14.3%

1 ended early

Currently Active

2

trials recruiting

Total Trials

9

all time

Status Distribution
Active(2)
Completed(6)
Terminated(1)

Detailed Status

Completed6
Withdrawn1
Active, not recruiting1
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
9
Active
2
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 15 (55.6%)
Phase 33 (33.3%)
Phase 41 (11.1%)

Trials by Status

withdrawn111%
completed667%
active_not_recruiting111%
recruiting111%

Recent Activity

2 active trials
Showing 5 of 9
active_not_recruitingphase_1

A Study of ABBV-295 Subcutaneous Injections to Assess Pharmacokinetics and Adverse Events in Healthy Adult Women Participants With Overweight or Obesity Taking Oral Contraceptives

NCT07414784
completedphase_1

A Study of Elenestinib in Healthy Adult Female Participants

NCT07388511
recruitingphase_4

Contraceptive Hormone and Reward Measurement (CHARM Study)

NCT05058872
completedphase_1

A Study to Evaluate the Drug Interaction Between Povorcitinib and the Oral Contraceptive Levonorgestrel/Ethinyl Estradiol in Healthy Adult Females

NCT06380205
withdrawnphase_1

Study Evaluating the Bioequivalence of Levonorgestrel/Ethinyl Estradiol Combinations in Cycling Women

NCT00447863
View all 9 trials

Clinical Trials (9)

Showing 9 of 9 trials
NCT07414784Phase 1

A Study of ABBV-295 Subcutaneous Injections to Assess Pharmacokinetics and Adverse Events in Healthy Adult Women Participants With Overweight or Obesity Taking Oral Contraceptives

Active Not Recruiting
NCT07388511Phase 1

A Study of Elenestinib in Healthy Adult Female Participants

Completed
NCT05058872Phase 4

Contraceptive Hormone and Reward Measurement (CHARM Study)

Recruiting
NCT06380205Phase 1

A Study to Evaluate the Drug Interaction Between Povorcitinib and the Oral Contraceptive Levonorgestrel/Ethinyl Estradiol in Healthy Adult Females

Completed
NCT00447863Phase 1

Study Evaluating the Bioequivalence of Levonorgestrel/Ethinyl Estradiol Combinations in Cycling Women

Withdrawn
NCT00161681Phase 3

Study Evaluating Levonorgestrel/Ethinyl Estradiol (LNG/EE) in PMS

Completed
NCT00319163Phase 1

Study Comparing Two Manufacturing Processes for Levonorgestrel 90 mg/Ethinyl Estradiol 20 mg (LNG/EE) in Healthy, Cycling Women

Completed
NCT00128934Phase 3

Study Evaluating Combination of Levonorgestrel (LNG) and Ethinyl Estradiol (EE) in Premenstrual Dysphoric Disorder

Completed
NCT00195559Phase 3

Study Evaluating Combination of Levonorgestrel and Ethinyl Estradiol in Pre-Menstrual Dysphoric Disorder

Completed

All 9 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
9